Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-03

Clinical Trial Update: Feru-guard for Behavioral Symptoms in Dementia [Phase 2]

View source ↗

Summary

Phase 2 trial update for Feru-guard targeting behavioral and psychiatric symptoms in dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Feru-guard

Snippet

Sponsor: Glovia Co., Ltd. | Conditions: Behavioral and Psychiatric Symptoms of Dementia | Phase 2 | Status: UNKNOWN